ArticleACR open rheumatology2020

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 Study.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.